Riskpilot← Back to searchSign inGet full accessHomeopathuset Söderström Aktiebolag
ABActiveOrg 5563584001Vedtjära 322Traditional, complementary and alternative medicine activities · NACE 8696Est. 19894 employees
Revenue 2024
SEK 5,9M
-4% vs 2023
EBITDA margin
1.2%
+129% vs 2023
Equity ratio
46.7%
Financial strength
Net profit 2024
SEK -25K
+90% vs 2023
| Revenue | SEK 5,9M | -4% |
| EBITDA | SEK 71K | +129% |
| Net profit | SEK -25K | +90% |
| Total assets | SEK 2,3M | +0% |
| Equity | SEK 1,1M | -2% |
| Employees | 4 | — |
Legal name
Homeopathuset Söderström Aktiebolag
Org number
5563584001
Legal form
Aktiebolag
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
26 april 1989
Share capital
SEK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utföra behandling med akupunktur samt alternativ behandling ävensom idka annan därmed förenlig verksamhet.
Address
Vedtjära 322
Email
info@homeopathuset.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 277 | 6 027 | 6 163 | 6 148 | 5 930 |
| Staff expenses | — | — | — | — | −2 623 |
| EBITDA | −92 | −222 | −316 | −249 | 71 |
| Depreciation & amort. | −42 | −108 | −97 | −0 | −83 |
| EBIT | −134 | −330 | −413 | −249 | −12 |
| Net financials | −3 | −7 | −8 | 5 | −13 |
| Profit before tax | −137 | −337 | −422 | −244 | −25 |
| Tax | −0 | −0 | −0 | −5 | — |
| Net profit | −137 | −337 | −422 | −249 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 345 | 2 961 | 2 660 | 2 286 | 2 295 |
| Equity | 2 404 | 2 067 | 1 645 | 1 096 | 1 071 |
| Long-term debt | 271 | 267 | 245 | 219 | 193 |
| Short-term debt | 670 | 628 | 770 | 971 | 1 031 |
| Total debt | 941 | 895 | 1 015 | 1 190 | 1 224 |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
46.7%
This company
38.2%
Market median
+22% vs market
20202024
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20202024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20202024
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20202024
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ES Audit | Audit | 2024 |
| Former (1) | ||
SK Chief Auditor | Chief Auditor | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Chairman | 2022 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Homeopathuset Söderström Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Susanne Lundholm | Audit | 0 companies |
| Sara Kristina Persson | Chief Auditor | 0 companies |
| Anna Christina Hedberg | Board of Directors | 0 companies |
| Ingegerd Elisabeth Söderström | Chairman | 0 companies |
| Mats Olof Söderström | Board of Directors | 0 companies |
| Hans Folke Söderström | Board of Directors | 0 companies |
| Ester Liselott Andersson | Deputy Board Member | 0 companies |